Cancer Research
- Raptor Pharmaceuticals Corp. Announces Presentation At 5th International Cystinosis Conference 2008
-
contact: The Ruth Group Sara Ephraim (investors) Janine McCargo (media) +1-646-536-7002 +1-646-536-7033 ...
Article - Anna Ohlden - Jun 23 2008 - 6:33am
- European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment Of Opioid-Induced Constipation (OIC) In Adva
-
further media information please contact: Gill Markham, Assistant Vice President, Communications Europe, ...
Article - Anna Ohlden - Jul 7 2008 - 1:30pm
- Raptor Pharmaceuticals Expands Board Of Directors And Scientific Advisory Board
-
information, please contact: The Ruth Group Sara Ephraim (investors) Janine McCargo (media) +1-646-536-7002 ...
Article - Anna Ohlden - Jul 14 2008 - 6:32am
- Raptor Pharmaceuticals Enters Collaboration Agreement With UC San Diego In Liver Disease
-
statements. For more information, please contact: The Ruth Group Sara Ephraim (investors) / Janine McCargo ...
Article - Anna Ohlden - Jul 16 2008 - 6:32am
- Results From The SEAS (Simvastatin And Ezetimibe In Aortic Stenosis) Study
-
and safe. For contact, Terje R. Pedersen, MD, Professor of Medicine, Head of the Centre for Preventive ...
Article - Anna Ohlden - Jul 21 2008 - 12:32pm
- Positive SPA Reply From The FDA For TopoTarget's Pivotal Trial With Belinostat In PTCL
-
TopoTarget A/S For further information, please contact: Ulla Hald Buhl, Telephone, +45-39-17-83-92; Director ...
Article - Anna Ohlden - Sep 5 2008 - 10:33am
- Roche To Present Data Showing Progress In Treating Lung, Gastric And Brain Cancers At ESMO
-
the event by contacting acameron@galliardhealth.com Notes to Editors- Breast Cancer is the most common ...
Article - Anna Ohlden - Sep 10 2008 - 12:32am
- Latest RAD001 Study Results Show Further Increase In Time Without Tumour Growth In Patients With Advanced Kidney Cancer
-
contact: Sally Robinson, Novartis Pharmaceuticals UK Ltd, Tel: +44(0)1276-692255, Fax: +44(0)1276-698605, ...
Article - Anna Ohlden - Sep 17 2008 - 8:32am
- Merck Serono Announces Initiation Of The ORACLE MS Trial To Evaluate Cladribine Tablets In Patients At Risk Of Developing Multip
-
by contacting the Company or visiting its website. Additional therapeutic options are currently under ...
Article - Anna Ohlden - Sep 18 2008 - 1:31am
- Results From IMPROVE Study Show Therapeutic Effect Of New Formulation Of Rebif(R) At 16 Weeks In Patients With Multiple Sclerosi
-
contacting the Company or visiting its website. Additional therapeutic options are currently under ...
Article - Anna Ohlden - Sep 22 2008 - 1:31am
Know Science And Want To Write?
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
